Regulation of autophagy by ceramide-CD95-PERK signaling

Margaret A Park1, Guo Zhang, James Norris

  • 1Department of Biochemistry, Virginia Commonwealth University, Richmond, Virginia 23298-0035, USA.

Autophagy
|August 23, 2008
PubMed

Insights

Ceramide-CD95 signaling triggers both cell death via caspase-8 and cell survival via autophagy. This dual pathway, regulated by PERK, presents potential therapeutic targets for cancer and liver diseases.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Understanding cell survival mechanisms in transformed and primary cells is crucial for developing targeted therapies.
  • Sorafenib, vorinostat, bile acids, and MEK1/2 inhibitors are used in treating various diseases, but their precise effects on cell fate require elucidation.

Purpose of the Study:

  • To investigate the regulation of cell survival and death pathways in response to specific drug treatments.
  • To elucidate the roles of ceramide, CD95 death receptor, and PERK signaling in determining cell fate.

Main Methods:

  • Utilized transformed and primary cell systems treated with sorafenib, vorinostat, bile acid, and MEK1/2 inhibitors.
  • Assessed ceramide generation, CD95 death receptor activation, pro-caspase 8 cleavage, and PERK/eIF2alpha phosphorylation.
  • Investigated autophagy markers (ATG5, LC3 processing, GFP-LC3 vesicularization) and employed ATG5 knockdown.

Main Results:

  • Ceramide generation and CD95 death receptor activation were key to drug-induced toxicity, leading to pro-caspase 8 activation.
  • CD95 signaling concurrently activated autophagy pathways, evidenced by increased ATG5, LC3 processing, and GFP-LC3 vesicularization.
  • PKR-like endoplasmic reticulum kinase (PERK) played a dual role, promoting apoptosis while also inducing protective autophagy.

Conclusions:

  • Ceramide-CD95 signaling orchestrates a balance between apoptosis and autophagy, dictating cell fate.
  • PERK signaling acts as a critical switch, influencing both cell death and survival pathways.
  • Targeting death receptor-induced apoptosis and autophagy offers potential therapeutic strategies for diseases involving aberrant cell survival.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...